KORU Medical Systems, Inc.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$11M
↑+23.3% +$2Mvs FY2024 (Q4)
Gross Profit
$7M
↑+22.6% +$1Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $11M | $9M |
| COGS | $4M | $3M |
| Gross Profit | $7M | $6M |
| R&D | $1M | $1M |
| SG&A | $6M | $6M |
| D&A | $179K | $211K |
| Other OpEx | $0 | $0 |
| Operating Income | $0 | $0 |
| Interest Exp. | $0 | $0 |
| Other Non-Op | $0 | $0 |
| Pretax Income | $0 | $0 |
| Tax | $0 | $0 |
| Net Income | $0 | $0 |
QuarterCharts · SEC EDGAR data · KRMD · Comparing FY2025 (Q4) vs FY2024 (Q4)